The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Enhanced Expression of Transgenes from Adeno-Associated Virus Vectors with the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element: Implications for Gene Therapy
Abstract
The woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) evolved to stimulate the expression of intronless viral messages. To determine whether this ability to enhance expression could be useful in nonviral and heterologous viral gene delivery systems, we analyzed the ability of the WPRE to elevate the expression of a cDNA encoding the green fluorescent protein (GFP) in these contexts. We find that the WPRE can stimulate the expression of GFP when the gene is delivered by transfection or transduction with recombinant adeno-associated virus (AAV). Enhancement occurred both during transient expression and when the gene is stably incorporated into the genome of target cells. This enhancement required that the WPRE be located in cis within the GFP message, and was observed in both transformed cell lines and primary human fibroblasts. These results demonstrate that the WPRE will be an effective tool for increasing the long-term expression of transgenes in gene therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“WPRE is a 600 bp long tripartite element containing gamma, alpha, and beta elements, in the given order [16] and contributes to the strong expression of transgenes in AAV systems [11-13].”
From Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons (2014) · cites this paper as [11]
In the citing paper
“The woodchuck hepatitis post-transcriptional regulatory element (WPRE) is often included in AAV cassettes to improve viral titer and transduction efficiency via stabilizing mRNA and regulating transcriptional termination [26, 27].”
From Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside (2024) · cites this paper as [26]
Citations
Cites
Tsien, R. Y. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.509 · Cited by 6,178
Xiao, X., Li, J., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2224-2232.1998 · Cited by 1,381
Malim, M. H., Hauber, J., Le, S.-Y., Maizel, J. V., & Cullen, B. R. (1989) · Nature · doi:10.1038/338254a0 · Cited by 1,280
Zufferey, R., Donello, J. E., Trono, D., & Hope, T. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2886-2892.1999 · Cited by 1,030
Self-citationXiao, X., Li, J., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8098-8108.1996 · Cited by 913
Samulski, R. J., Chang, L., & Shenk, T. E. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.3822-3828.1989 · Cited by 742
Quantitative analysis of the packaging capacity of recombinant adeno-associated virus
Dong, J.-Y., Fan, P.-D., & Frizzell, R. A. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.17-2101 · Cited by 583
Snyder, R. O., Miao, C. H., Patijn, G. A., Spratt, S. K., Danos, O., Nagy, D., Gown, A. M., Winther, B., Meuse, L. A., Cohen, L. K., et al. (1997) · Nature Genetics · doi:10.1038/ng0797-270 · Cited by 579
Fisher, K. J., Gao, G. P., Weitzman, M. D., DeMatteo, R. P., Burda, J. F., & Wilson, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.520-532.1996 · Cited by 546
Self-citationFlotte, T. R., Afione, S. A., Conrad, C., McGrath, S. A., Solow, R., Oka, H., Zeitlin, P. L., Guggino, W. B., & Carter, B. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10613 · Cited by 490
Research works printed but not linked: 2
- BUCHMAN A.R., 1988, Mol. Cell. Biol., 8, 4395, 10.1128/MCB.8.10.4395 · DOI
- FLOTTE T.R., 1995, Gene Ther., 2, 357
Cited by
Sorted by citations
Items 101–200 of 278
Stem cell-based delivery of brain-derived neurotrophic factor gene in the rat retina
Park, H.-Y. L., Kim, J., Kim, H. S., & Park, C. K. (2012) · Brain Research · doi:10.1016/j.brainres.2012.06.006 · Cited by 43
Adeno‐associated virus‐mediated gene delivery approaches for the treatment of CNS disorders
Terzi, D., & Zachariou, V. (2008) · Biotechnology Journal · doi:10.1002/biot.200800284 · Cited by 43
Genetically encoded fluorescent sensors for imaging neuronal dynamics in vivo
Day‐Cooney, J., Dalangin, R., Zhong, H., & Mao, T. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15608 · Cited by 43
Huang, W., Liu, X., Queen, N. J., & Cao, L. (2017) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2017.06.002 · Cited by 41
Improved Motor Nerve Regeneration by SIRT1/Hif1a-Mediated Autophagy
Romeo-Guitart, D., Leiva-Rodríguez, T., Forés, J., & Casas, C. (2019) · Cells · doi:10.3390/cells8111354 · Cited by 40
Wang, L., Wang, H., Morizono, H., Bell, P. L., Jones, D., Lin, J., McMenamin, D., Yu, H., Batshaw, M. L., & Wilson, J. M. (2011) · Gene Therapy · doi:10.1038/gt.2011.111 · Cited by 41
Urea-cycle disorders as a paradigm for inborn errors of hepatocyte metabolism
Mian, A. I., & Lee, B. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02437-1 · Cited by 41
Advances in AAV-mediated gene transfer for the treatment of inherited disorders
Hildinger, M., & Auricchio, A. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201153 · Cited by 40
Focused Update on AAV-Based Gene Therapy Clinical Trials for Inherited Retinal Degeneration
Fuller-Carter, P. I., Basiri, H., Harvey, A. R., & Carvalho, L. S. (2020) · BioDrugs · doi:10.1007/s40259-020-00453-8 · Cited by 41
Approaches and Vectors for Efficient Cochlear Gene Transfer in Adult Mouse Models
Zhao, Y. F., Zhang, L., Wang, D., Chen, B., & Shu, Y. (2022) · Biomolecules · doi:10.3390/biom13010038 · Cited by 39
KLEIN, R., Dayton, R. D., LIN, W., & Dickson, D. W. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.02.001 · Cited by 39
Comparison of gene expression after intraperitoneal delivery of AAV2 or AAV5 in utero
Lipshutz, G. S., Titre, D., Brindle, M. E., Bisconte, A. R., Contag, C. H., & Gaensler, K. M. L. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00132-1 · Cited by 37
Zeng, J., Du, J., Lin, J., Bak, X. Y., Wu, C., & Wang, S. (2009) · Molecular Therapy · doi:10.1038/mt.2009.124 · Cited by 38
Prima, V., Tennant, M., Gorbatyuk, O. S., Muzyczka, N., Scarpace, P. J., & Zolotukhin, S. (2004) · Endocrinology · doi:10.1210/en.2003-1376 · Cited by 38
Jia, F., Lv, P., Miao, H., Shi, X., Mei, H., Li, L., Xu, X., Tao, S., & Xu, F. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00063 · Cited by 36
Viral vectors for gene delivery to the inner ear
Maguire, C. A., & Corey, D. P. (2020) · Hearing Research · doi:10.1016/j.heares.2020.107927 · Cited by 33
Klugmann, M., & Szumlinski, K. K. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c369f · Cited by 34
Hlavatý, J., Schittmayer, M., Stracke, A., Jandl, G., Knapp, E., Felber, B. K., Salmons, B., Günzburg, W. H., & Renner, M. (2005) · Virology · doi:10.1016/j.virol.2005.06.037 · Cited by 33
Reversibility of motor dysfunction in the rat model of NGLY1 deficiency
Asahina, M., Fujinawa, R., Hirayama, H., Tozawa, R., Kajii, Y., & Suzuki, T. (2021) · Molecular Brain · doi:10.1186/s13041-021-00806-6 · Cited by 32
Efficient delivery of RNA Interference to peripheral neurons in vivo using herpes simplex virus
Anesti, A., Peeters, P. J., Royaux, I. E., & Coffin, R. S. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn371 · Cited by 31
Miyadera, K., Santana, E., Roszak, K. P., Iffrig, S., Visel, M., Iwabe, S., Boyd, R. F., Bartoe, J. T., Sato, Y., Gray, A. P., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117038119 · Cited by 30
Luebke, A. E., Rova, C. R. L., Doersten, P. G. V., & Poulsen, D. J. (2009) · Advances in oto-rhino-laryngology · doi:10.1159/000218209 · Cited by 30
Hybrid vector designs to control the delivery, fate and expression of transgenes
Lam, P. Y. P., & Breakefield, X. O. (2000) · The Journal of Gene Medicine · doi:10.1002/1521-2254(200011/12)2:6 · Cited by 29
Recombinant adeno-associated virus vector design and gene expression in the mammalian brain
Paterna, J., & Büeler, H. (2002) · Methods · doi:10.1016/s1046-2023(02)00225-6 · Cited by 29
Strategies to improve safety profile of AAV vectors
Suoranta, T., Laham-Karam, N., & Ylä‐Herttuala, S. (2022) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2022.1054069 · Cited by 32
Han, S. R., Lee, C. H., Im, J. Y., Kim, J. H., Kim, J. H., Kim, S. J., Cho, Y. W., Kim, E., Kim, Y., Ryu, J.-H., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.10.036 · Cited by 28
Functional viromic screens uncover regulatory RNA elements
Seo, J. J., Jung, S. J., Yang, J.-H., Choi, D.-E., & Kim, V. N. (2023) · Cell · doi:10.1016/j.cell.2023.06.007 · Cited by 29
Bell, P., Wang, L., Chen, S.-J., Yu, H., Zhu, Y., Nayal, M., He, Z., White, J., Lebel-Hagan, D., & Wilson, J. M. (2016) · Human Gene Therapy Methods · doi:10.1089/hgtb.2016.039 · Cited by 26
Fagoe, N. D., Eggers, R., Verhaagen, J., & Mason, M. R. J. (2014) · Gene Therapy · doi:10.1038/gt.2013.71 · Cited by 27
Zingg, B., Dong, H., Tao, H. W., & Zhang, L. I. (2022) · Current Protocols · doi:10.1002/cpz1.339 · Cited by 32
de Wit, J., Eggers, R., Evers, R. W., Ċastrén, E., & Verhaagen, J. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4543-05.2006 · Cited by 27
Wang, L., Wang, Z., Zhang, F., Zhu, R., Bi, J., Wu, J., Zhang, H., Liu, H., Kong, W., Yu, B., et al. (2016) · International Journal of Medical Sciences · doi:10.7150/ijms.14152 · Cited by 29
Adeno-Associated Viral Vectors for Gene Therapy of Inherited Retinal Degenerations
Flannery, J. G., & Visel, M. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-080-9_25 · Cited by 26
Improving the Post-Transcriptional Aspects of Lentiviral Vectors
Hope, T. J. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-56114-6_9 · Cited by 26
Self-citationEnhancing Prostate‐Cancer‐Specific MRI by Genetic Amplified Nanoparticle Tumor Homing
Zhao, Y., Peng, J., Yang, J., Zhang, E., Huang, L. F., Yang, H. W., Kakadiaris, E., Li, J., Yan, B., Shang, Z., et al. (2019) · Advanced Materials · doi:10.1002/adma.201900928 · Cited by 25
Wang, L., Muthuramu, I., Somanathan, S., Zhang, H., Bell, P. L., He, Z., Yu, H., Zhu, Y., Tretiakova, A. P., & Wilson, J. M. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.04.017 · Cited by 25
Selkirk, J. V., Stiefel, T. H., Stone, I. M., Naeve, G. S., Foster, A. C., & Poulsen, D. J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04059.x · Cited by 25
Matsuzaki, Y., Konno, A., Mukai, R., Honda, F., Hirato, M., Yoshimoto, Y., & Hirai, H. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9777-6 · Cited by 24
Chu, T. L., Chen, P., Yu, A. X., Kong, M., Tan, Z., Tsang, K. Y., Zhou, Z., & Cheah, K. S. E. (2023) · eLife · doi:10.7554/elife.82142 · Cited by 20
Persistent expression of biologically active anti-HER2 antibody by AAVrh.10-mediated gene transfer
Wang, G., Qiu, J., Wang, R., Krause, A., Boyer, J. L., Hackett, N. R., & Crystal, R. G. (2010) · Cancer Gene Therapy · doi:10.1038/cgt.2010.11 · Cited by 23
Ding, M., Cao, X., Xu, H.-N., Fan, J., Huang, H.-L., Yang, D.-Q., Li, Y.-H., Wang, J., Li, R., & Liu, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035153 · Cited by 23
Leiva-Rodríguez, T., Romeo-Guitart, D., Marmolejo-Martínez-Artesero, S., Herrando‐Grabulosa, M., Bosch, A., Forés, J., & Casas, C. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0682-y · Cited by 25
Shi, J., Liu, Y., Zheng, Y., Guo, Y., Zhang, J., Cheung, P., Xu, R., & Zheng, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1227 · Cited by 23
Richard, E., Géronimi, F., Lalanne, M., Ged, C., Redonnet‐Vernhet, I., Lamrissi‐Garcia, I., Gerson, S. L., de Verneuil, H., & Moreau‐Gaudry, F. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.407 · Cited by 23
Human Retinal Explant Culture for Ex Vivo Validation of AAV Gene Therapy
Orlans, H. O., Edwards, T. L., Silva, S. R. D., Patrício, M. I., & MacLaren, R. E. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7522-8_21 · Cited by 22
Genetic Constructs for the Control of Astrocytes’ Activity
Borodinova, A. A., Balaban, P. M., Борисович, Б. И., Salmina, A. B., & Власова, О. Л. (2021) · Cells · doi:10.3390/cells10071600 · Cited by 22
Increased in vitro and in vivo transgene expression levels mediated through cis‐acting elements
Johansen, J. L., Tornøe, J., Møller, A., & Johansen, T. E. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.444 · Cited by 22
Boulaire, J., Balani, P., & Wang, S. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.02.007 · Cited by 22
Intravenous delivery of adeno-associated viral gene therapy in feline GM1 gangliosidosis
Gross, A. L., Gray‐Edwards, H. L., Bebout, C. N., Ta, N. L., Nielsen, K., Brunson, B. L., Mercado, K. R. L., Osterhoudt, D. E., Batista, A. R., Maitland, S. A., et al. (2021) · Brain · doi:10.1093/brain/awab309 · Cited by 20
A Novel Gene Expression System: Non‐Viral Gene Transfer for Hemophilia as Model Systems
Miao, C. H. (2005) · Advances in genetics · doi:10.1016/s0065-2660(05)54007-0 · Cited by 21
Wilsey, J. T., Zolotukhin, S., Prima, V., Shek, E. W., Matheny, M. K., & Scarpace, P. J. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301835 · Cited by 21
Cotugno, G., Annunziata, P., Barone, M. V., Karali, M., Banfi, S., & Auricchio, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033286 · Cited by 21
Montesinos, M. S., Chen, Z., & Young, S. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00713.2011 · Cited by 21
Evaluation of combinatorial cis-regulatory elements for stable gene expression in chicken cells
Seo, H. W., Kim, T. M., Choi, J. W., Han, B. K., Song, G., & Han, J. Y. (2010) · BMC Biotechnology · doi:10.1186/1472-6750-10-69 · Cited by 20
López‐Font, I., Sogorb‐Esteve, A., Javier‐Torrent, M., Brinkmalm, G., Herrando‐Grabulosa, M., García-Lareu, B., Turón‐Sans, J., Rojas‐García, R., Lleó, A., Saura, C. A., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.12.021 · Cited by 19
Intersectional targeting of defined neural circuits by adeno‐associated virus vectors
Weinholtz, C. A., & Castle, M. J. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24774 · Cited by 19
Lam, B. L., Davis, J. L., & Gregori, N. Z. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000385 · Cited by 19
Callendret, B., Lorin, V., Charneau, P., Marianneau, P., Contamin, H., Betton, J., van der Werf, S., & Escriou, N. (2007) · Virology · doi:10.1016/j.virol.2007.01.012 · Cited by 19
Schwenter, F., Déglon, N., & Aebischer, P. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.338 · Cited by 19
Nam, J. H., Richie, C. T., Harvey, B. K., & Voutilainen, M. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-65735-5 · Cited by 18
Du, J., Zeng, J., Zhao, Y. H., Boulaire, J., & Wang, S. (2009) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2009.06.017 · Cited by 18
Doherty, F. C., Schaack, J. B., & Sladek, C. D. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.02.026 · Cited by 18
Hermann, F. G., Martinius, H., Egelhofer, M., Giroglou, T., Tonn, T., Roth, S. D., Zahn, R. C., Schult-Dietrich, P., Alexandrov, A., Dietrich, U., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2006.158 · Cited by 18
Vaessen, S. F. C., Veldman, R. J., Comijn, E. M., Snapper, J., Sierts, J. A., van den Oever, K., Beattie, S. G., Twisk, J., & Kuivenhoven, J. A. (2009) · The Journal of Gene Medicine · doi:10.1002/jgm.1344 · Cited by 18
Pironet, A., Syam, N., Vandewiele, F., den Haute, C. V., Kerselaers, S., Pinto, S., Velde, G. V., Gijsbers, R., & Vennekens, R. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00802 · Cited by 17
Liu, C., Li, J., Yao, Q., Gao, Z., Cheng, Y., Zhou, M., Tang, Y., Sun, L., Dai, J., Cao, G., et al. (2020) · Veterinary Microbiology · doi:10.1016/j.vetmic.2020.108578 · Cited by 16
Lee, Y., Cosgrave, A. S., Glover, C. P. J., Bienemann, A. S., Heywood, D. J., Hobson, R. J., & Uney, J. B. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.694 · Cited by 17
Lindberg, I., Shu, Z., Lam, H. A., Helwig, M., Yucer, N., Laperle, A., Svendsen, C. N., Monte, D. A. D., & Maidment, N. T. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-213053 · Cited by 15
Rai, R., Steinberg, Z., Romito, M., Zinghirino, F., Hu, Y., White, N., Naseem, A., Thrasher, A. J., Turchiano, G., & Cavazza, A. (2024) · Human Gene Therapy · doi:10.1089/hum.2023.100 · Cited by 14
Research and perspectives in neurosciences
Reul, J., & Linthorst, A. C. E. (2000) · Cited by 15
Deng, W., Yan, Z., Dinculescu, A., Pang, J., Teusner, J. T., Cortez, N. G., Berns, K. I., & Hauswirth, W. W. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1247 · Cited by 15
Bioluminescence imaging after HSV amplicon vector delivery into brain
Pike, L. S., Petravicz, J., & Wang, S. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.909 · Cited by 15
GRP78 Overexpression Triggers PINK1-IP3R-Mediated Neuroprotective Mitophagy
Leiva-Rodríguez, T., Romeo-Guitart, D., Herrando‐Grabulosa, M., Muñoz‐Guardiola, P., Polo, M., Bañuls, C., Petegnief, V., Bosch, A., Lizcano, J. M., Apostolova, N., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9081039 · Cited by 15
Dayton, R. D., Wang, D. B., Cain, C. D., Schrott, L. M., Ramirez, J. J., King, M. A., & Klein, R. L. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.12.002 · Cited by 16
Yamauchi, K., Okamoto, S., Ishida, Y., Konno, K., Hoshino, K., Furuta, T., Takahashi, M., Koike, M., Isa, K., Watanabe, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-19085-9 · Cited by 13
Improved microRNA suppression by WPRE-linked tough decoy microRNA sponges
Hollensen, A. K., Thomsen, R., Bak, R. O., Petersen, C. C., Ermegaard, E. R., Aagaard, L., Damgaard, C. K., & Mikkelsen, J. G. (2017) · RNA · doi:10.1261/rna.061192.117 · Cited by 15
Use of feline herpesvirus as a vaccine vector offers alternative applications for feline health
Cottingham, E., Johnstone, T., Hartley, C. A., & Devlin, J. M. (2021) · Veterinary Microbiology · doi:10.1016/j.vetmic.2021.109210 · Cited by 12
AAV2 vector optimization for retinal ganglion cell-targeted delivery of therapeutic genes
Chaqour, B., Duong, T. T., Yue, J., Liu, T., Camacho, D., Dine, K. E., Esteve-Rudd, J., Ellis, S., Bennett, J., Shindler, K. S., et al. (2024) · Gene Therapy · doi:10.1038/s41434-023-00436-8 · Cited by 12
Li, P., Lan, Y., Wu, X., Bai, W., Li, K., Wang, H.-T., Hu, G., Zhang, L., Zhang, F., & Xu, Z. (2011) · Journal of Virological Methods · doi:10.1016/j.jviromet.2011.10.005 · Cited by 12
Real, G., Monteiro, F., Burger, C., & Alves, P. M. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3392-2 · Cited by 11
Zhang, Z., Chen, W., Ma, C., Zhao, P., Duan, L., Zhang, F., Sun, A., Li, Y., Su, H., Li, S., et al. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.03.032 · Cited by 12
Williams, R. R., Pearse, D. D., Tresco, P. A., & Bunge, M. B. (2011) · The Journal of Gene Medicine · doi:10.1002/jgm.1628 · Cited by 11
Tetlow, A. M., Jackman, B. M., Alhadidy, M. M., Muskus, P. C., Morgan, D., & Gordon, M. N. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.06.014 · Cited by 10
Adeno-Associated Viral Gene Therapy for Retinal Disorders
Silva, S. R. D., McClements, M. E., Hankins, M. W., & MacLaren, R. E. (2015) · Neuromethods · doi:10.1007/978-1-4939-2306-9_9 · Cited by 10
E2F4-Based Gene Therapy Mitigates the Phenotype of the Alzheimer's Disease Mouse Model 5xFAD
López‐Sánchez, N., Garrido‐García, A., Ramón‐Landreau, M., Cano‐Daganzo, V., & Frade, J. M. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01151-1 · Cited by 11
Targeted Integration by Adeno-Associated Virus
Weitzman, M. D., Young, S. M., Cathomen, T., & Samulski, R. J. (2003) · Humana Press eBooks · doi:10.1385/1-59259-304-6:201 · Cited by 10
Self-citationPocock, G. M., Zimdars, L. L., Yuan, M., Eliceiri, K. W., Ahlquist, P., & Sherer, N. M. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-08-0612 · Cited by 9
Retroviral Vector Technology for Gene Therapy: History, Current Landscape, and Future Prospects
Jaballah, S. A., Ali, L. M., Jehad, M. A., Akhlaq, S., Rizvi, T. A., & Mustafa, F. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169473 · Cited by 10
Liu, Y. K., Kelly, M. A., Sexton, T. J., & Neumaier, J. F. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.032 · Cited by 10
Robert, D. B., Mahon, F., Richard, E., Étienne, G., de Verneuil, H., & Moreau‐Gaudry, F. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00011-x · Cited by 9
Wang, L., Menon, S. A., Bolin, S. R., & Bello, L. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8775-8782.2003 · Cited by 9
Recombinant Adeno-Associated Viral Vectors in the Nervous System
Bürger, C., Nash, K. R., & Mandel, R. J. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.ft-64 · Cited by 9
Luchicchi, A., Pattij, T., Viaña, J. N. M., de Kloet, S. F., & Marchant, N. J. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.109004 · Cited by 8
Intracellular efficacy of tumor‐targeting group I intron‐based trans‐splicing ribozyme
Kwon, B. S., Jeong, J. S., Won, Y.-S., Lee, C. H., Yoon, K., Jung, M. H., Kim, I., & Lee, S. (2011) · The Journal of Gene Medicine · doi:10.1002/jgm.1545 · Cited by 8
Exogenous Peptide and Protein Expression Levels Using Retroviral Vectors in Human Cells
Sandrock, T. M., Risley, B., Richards, B. T., Poritz, M. A., Austin, H. A., Yoo, S., Kim, M. K. H., Roth, B. L., Repetny, K., Hsu, F., et al. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0476 · Cited by 8
Oka, K., & Chan, L. (2005) · Humana Press eBooks · doi:10.1385/1-59259-850-1:329 · Cited by 8
Mateu-Bosch, A., Segur‐Bailach, E., Muñoz‐Moreno, E., Barallobre, M. J., Arbonés, M. L., Gea‐Sorlí, S., Tort, F., Ribes, A., García‐Villoria, J., & Fillat, C. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101276 · Cited by 7
GCaMP expression in retinal ganglion cells characterized using a low-cost fundus imaging system
Chang, Y.-C., Walston, S. T., Chow, R. H.-P., & Weiland, J. D. (2017) · Journal of Neural Engineering · doi:10.1088/1741-2552/aa7ded · Cited by 7
Gene Therapy for Retinal Disease: What Lies Ahead
MacLaren, R. E. (2015) · Ophthalmologica · doi:10.1159/000438872 · Cited by 7
Bantounas, I., Glover, C. P. J., Kelly, S., Iseki, S., Phylactou, L. A., & Uney, J. B. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20389 · Cited by 7
Metadata
- Authors
- Loeb, J. E., Cordier, W. S., Harris, M. E., Weitzman, M. D., & Hope, T. J.
- Affiliations
- Salk Institute for Biological Studies (US)
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1999-09-20
- Volume
- 10
- Issue
- 14
- Pages
- 2295-2305
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2142334980
- Cited by
- 279
- References
- 35
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 18 · 2023: 8 · 2022: 10 · 2021: 15 · 2020: 11 · 2019: 7 · 2018: 7 · 2017: 10 · 2016: 5 · 2015: 10 · 2014: 11 · 2013: 6 · 2012: 6
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Gene Therapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- woodchuck hepatitis virus, adeno-associated virus vectors, green fluorescent protein, gene therapy, cis-acting regulation, stable transfection, transduction, human fibroblasts, long-term transgene expression
- MeSH terms
- Dependovirus, Cell Line, Flow Cytometry, Genetic Vectors, Humans, Luminescent Proteins, Regulatory Sequences, Nucleic Acid, RNA Processing, Post-Transcriptional, RNA, Viral, Blotting, Western, Gene Expression Regulation, Viral, Hepatitis B Virus, Woodchuck, Gene Transfer Techniques, Transgenes, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review